Imidazo[1,2-b][1,2,4]triazines as c-Met inhibitors

Details for Australian Patent Application No. 2011269788 (hide)

Owner Incyte Corporation

Inventors Zhuo, Jincong; He, Chunhong; Yao, Wenqing

Agent Davies Collison Cave

Pub. Number AU-A-2011269788

PCT Pub. Number WO2011/162835

Priority 61/300,946 03.02.10 US

Filing date 2 February 2011

Wipo publication date 29 December 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/162835 Priority application(s): WO2011/162835

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011269796-Medical device inserters and processes of inserting and using medical devices

2011269604-Location method and location system for acquiring terminal location